These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29710850)

  • 1. Computational Characterization of Small Molecules Binding to the Human XPF Active Site and Virtual Screening to Identify Potential New DNA Repair Inhibitors Targeting the ERCC1-XPF Endonuclease.
    Gentile F; Barakat KH; Tuszynski JA
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29710850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided drug design of small molecule inhibitors of the ERCC1-XPF protein-protein interaction.
    Gentile F; Elmenoufy AH; Ciniero G; Jay D; Karimi-Busheri F; Barakat KH; Weinfeld M; West FG; Tuszynski JA
    Chem Biol Drug Des; 2020 Apr; 95(4):460-471. PubMed ID: 31891209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
    Gentile F; Tuszynski JA; Barakat KH
    J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule inhibitors of ERCC1-XPF protein-protein interaction synergize alkylating agents in cancer cells.
    Jordheim LP; Barakat KH; Heinrich-Balard L; Matera EL; Cros-Perrial E; Bouledrak K; El Sabeh R; Perez-Pineiro R; Wishart DS; Cohen R; Tuszynski J; Dumontet C
    Mol Pharmacol; 2013 Jul; 84(1):12-24. PubMed ID: 23580445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance.
    McNeil EM; Astell KR; Ritchie AM; Shave S; Houston DR; Bakrania P; Jones HM; Khurana P; Wallace C; Chapman T; Wear MA; Walkinshaw MD; Saxty B; Melton DW
    DNA Repair (Amst); 2015 Jul; 31():19-28. PubMed ID: 25956741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells.
    Arora S; Heyza J; Zhang H; Kalman-Maltese V; Tillison K; Floyd AM; Chalfin EM; Bepler G; Patrick SM
    Oncotarget; 2016 Nov; 7(46):75104-75117. PubMed ID: 27650543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy.
    McNeil EM; Melton DW
    Nucleic Acids Res; 2012 Nov; 40(20):9990-10004. PubMed ID: 22941649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and in vitro cell-free/cell-based biological evaluations of novel ERCC1-XPF inhibitors targeting DNA repair pathway.
    Elmenoufy AH; Gentile F; Jay D; Karimi-Busheri F; Yang X; Soueidan OM; Mani RS; Ciniero G; Tuszynski JA; Weinfeld M; West FG
    Eur J Med Chem; 2020 Oct; 204():112658. PubMed ID: 32738410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryo-EM structures of the XPF-ERCC1 endonuclease reveal how DNA-junction engagement disrupts an auto-inhibited conformation.
    Jones M; Beuron F; Borg A; Nans A; Earl CP; Briggs DC; Snijders AP; Bowles M; Morris EP; Linch M; McDonald NQ
    Nat Commun; 2020 Feb; 11(1):1120. PubMed ID: 32111838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple DNA binding domains mediate the function of the ERCC1-XPF protein in nucleotide excision repair.
    Su Y; Orelli B; Madireddy A; Niedernhofer LJ; Schärer OD
    J Biol Chem; 2012 Jun; 287(26):21846-55. PubMed ID: 22547097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domain mapping of the DNA binding, endonuclease, and ERCC1 binding properties of the human DNA repair protein XPF.
    McCutchen-Maloney SL; Giannecchini CA; Hwang MH; Thelen MP
    Biochemistry; 1999 Jul; 38(29):9417-25. PubMed ID: 10413517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure and DNA binding functions of ERCC1, a subunit of the DNA structure-specific endonuclease XPF-ERCC1.
    Tsodikov OV; Enzlin JH; Schärer OD; Ellenberger T
    Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11236-41. PubMed ID: 16076955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting DNA Repair in Tumor Cells via Inhibition of ERCC1-XPF.
    Elmenoufy AH; Gentile F; Jay D; Karimi-Busheri F; Yang X; Soueidan OM; Weilbeer C; Mani RS; Barakat KH; Tuszynski JA; Weinfeld M; West FG
    J Med Chem; 2019 Sep; 62(17):7684-7696. PubMed ID: 31369707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of the human ERCC1/XPF interaction domains reveals a complementary role for the two proteins in nucleotide excision repair.
    Tripsianes K; Folkers G; Ab E; Das D; Odijk H; Jaspers NG; Hoeijmakers JH; Kaptein R; Boelens R
    Structure; 2005 Dec; 13(12):1849-58. PubMed ID: 16338413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells.
    Heyza JR; Arora S; Zhang H; Conner KL; Lei W; Floyd AM; Deshmukh RR; Sarver J; Trabbic CJ; Erhardt P; Chan TH; Dou QP; Patrick SM
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical and functional interaction between the XPF/ERCC1 endonuclease and hRad52.
    Motycka TA; Bessho T; Post SM; Sung P; Tomkinson AE
    J Biol Chem; 2004 Apr; 279(14):13634-9. PubMed ID: 14734547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function and Interactions of ERCC1-XPF in DNA Damage Response.
    Faridounnia M; Folkers GE; Boelens R
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30563071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of individual ERCC1 and XPF subunits in DNA nucleotide excision repair.
    Gaillard PHL; Wood RD
    Nucleic Acids Res; 2001 Feb; 29(4):872-9. PubMed ID: 11160918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catechols and 3-hydroxypyridones as inhibitors of the DNA repair complex ERCC1-XPF.
    Chapman TM; Gillen KJ; Wallace C; Lee MT; Bakrania P; Khurana P; Coombs PJ; Stennett L; Fox S; Bureau EA; Brownlees J; Melton DW; Saxty B
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4097-103. PubMed ID: 26318993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-stranded DNA Binding by the Helix-Hairpin-Helix Domain of XPF Protein Contributes to the Substrate Specificity of the ERCC1-XPF Protein Complex.
    Das D; Faridounnia M; Kovacic L; Kaptein R; Boelens R; Folkers GE
    J Biol Chem; 2017 Feb; 292(7):2842-2853. PubMed ID: 28028171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.